Document Detail

Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study.
MedLine Citation:
PMID:  8611465     Owner:  NLM     Status:  MEDLINE    
In recent years clinical factors have largely surpassed alloimmunization as the predominant cause of platelet refractoriness. This makes it necessary to properly identify and weigh the non-immune factors that have a major impact of refractoriness. A case-control study is suitable for such an analysis, and to our knowledge has not previously been performed to assess this issue. Fifty-two refractory patients were compared with 52 control patients who were transfused at the same time. Only one transfusion event was analysed per patient. Clinical and laboratory data were recorded at the time of selected transfusion, and their association with refractoriness was investigated by the contingency table method and the Cox stepwise logistic regression. There were 16 (31%) patients with HLA antibodies in the index group and only one in the control group. The corrected count increment in the group of patients refractory due to HLA antibodies was significantly lower than that in non-alloimmunized refractory patients [median (range): 48.5 (-3560, 4614) and 4058 (-4417, 6886), respectively; U = 493, P < 0.0001]. In the multivariate analysis, factors associated with refractoriness were the presence of HLA antibodies (odds ratio (OR) 50.7; 95% CI 5.5-463); fever (odds ratio 7.2; 95% CI 2.5-21) and BMT because of chronic myeloid leukaemia (odds ratio 7.3; 95% CI 1.8-30). The latter two were the only factors that remained independently associated with refractoriness after excluding alloimmunized patients and their controls. We conclude that HLA antibodies are strongly associated with platelet transfusion refractoriness, but account for less than a third of these patients. Fever and BMT because of chronic myeloid leukaemia were the only non-immune factors independently associated with refractoriness.
I Alcorta; A Pereira; A Ordinas
Related Documents :
9371095 - Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic re...
9356785 - Variations of erythrocyte morphology in different pathologies.
6414355 - Clomiphene-responsive hypogonadism in sickle cell anemia.
7577635 - Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with co...
17952405 - Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antid...
19575355 - Asymmetric dimethylarginine (adma), symmetric dimethylarginine (sdma), arginine, and 8-...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of haematology     Volume:  93     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1996 Apr 
Date Detail:
Created Date:  1996-05-31     Completed Date:  1996-05-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  220-4     Citation Subset:  IM    
Service of Haemotherapy and Haemostasis, Hospital Clínic, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
HLA Antigens*
Middle Aged
Multivariate Analysis
Platelet Transfusion*
Risk Factors
Thrombocytopenia / immunology,  therapy*
Treatment Failure
Reg. No./Substance:
0/HLA Antigens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patie...
Next Document:  Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays.